PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12705756

Polydactylous Bowen's disease.

A Koch·J Schönlebe·G Haroske·E Köstler·U Wollina
View original source ↗Export metadata ↓

Abstract

Malignant nail tumours are rare. We report on a 52-year-old patient with chronic verrucous lesions of the nail bed of fingers and toes. Nail biopsy revealed polydactylous Bowen's disease. This is the first case reported with hand and foot lesions.

Explore related subjects

Bowen's DiseaseFingersHumansMaleMiddle AgedNail DiseasesSkin NeoplasmsToesCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Koch, J Schönlebe, G Haroske, E Köstler, U Wollina. 2003. Polydactylous Bowen's disease.. https://doi.org/10.1046/j.1468-3083.2003.00657.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

DNase1L2 degrades nuclear DNA during corneocyte formation.

The removal of keratinocyte (KC) nuclear DNA by deoxyribonucleases (DNases) is an important step in the formation of normal stratum corneum (SC). However, the molecular identity of the DNA-degrading enzymes has so far remained elusive. Here we show that the endonuclease DNase1-like 2 (DNase1L2) is preferentially expressed in the epidermis and that its expression correlates with terminal differentiation of KC in vitro and in vivo. In biopsies of normal skin, DNase1L2 mRNA was regularly found in suprabasal KC and DNase1L2 protein was highly abundant in the stratum granulosum. In contrast to normal skin, DNase1L2 expression was downregulated in parakeratotic epidermis such as in psoriatic lesions. When DNase1L2 gene expression was knocked down by small interfering RNA in a human skin equivalent model, nuclei were maintained through all layers of the SC. Taken together, our data demonstrate that DNase1L2 plays an essential role in DNA degradation during terminal differentiation of epidermal KC.

Bowen's Disease↗